Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Vir Biotechnology, Inc. (VIR) had Cost of Goods Sold of $0.03M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$64.07M |
|
$-42.92M |
|
|
Cost of Goods Sold |
$0.03M |
$64.04M |
|
$111.99M |
|
$-47.92M |
|
$4.86M |
|
$-43.06M |
|
$-43.06M |
|
$-42.92M |
|
$-42.92M |
|
$-42.92M |
|
$-42.92M |
|
$-47.92M |
|
$-43.47M |
|
138.52M |
|
138.52M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$514.08M |
|
$55.62M |
|
$488.74M |
|
$1.00B |
|
$92.81M |
|
-- |
|
$144.73M |
|
$237.55M |
|
$765.28M |
|
$740.49M |
|
$765.28M |
|
139.47M |
|
| Cash Flow Statement Financials | |
$-391.78M |
|
$310.37M |
|
$3.79M |
|
$318.69M |
|
$241.07M |
|
$-77.62M |
|
$49.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
99.96% |
|
-74.79% |
|
-74.79% |
|
-- |
|
-67.21% |
|
-66.99% |
|
$-396.36M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-5.61% |
|
-5.80% |
|
-4.28% |
|
-5.61% |
|
$5.49 |
|
$-2.86 |
|
$-2.83 |
|